Dintica Christina S, Bahorik Amber L, Xia Feng, Boscardin John, Yaffe Kristine
Department of Psychiatry and Behavioral Sciences, University of California, San Francisco.
Northern California Institute for Research and Education, San Francisco, California.
JAMA Neurol. 2025 Jun 9. doi: 10.1001/jamaneurol.2025.1536.
Prior studies of dementia incidence in the US often focused on narrow regions, leaving regional variation unclear and potential explanatory factors unknown.
To investigate geographic differences in dementia incidence across the US among older adults enrolled in the Veterans Health Administration (VHA) system.
DESIGN, SETTING, AND POPULATION: Cohort study spanning October 1999 to September 2021 with a mean follow-up time of 12.6 years. Data were analyzed from October 2023 to September 2024 among a random sample of 1 268 599 dementia-free veterans aged 65 years or older with available zip code information in locations across the US. We excluded 22 512 with missing zip codes, 265 850 with no follow-up, and 37 370 with prevalent dementia.
Geographical region categories across the US were defined using the Centers for Disease Control and Prevention (CDC) National Center for Chronic Disease Prevention and Health Promotion definition, which divides the US into 10 regions, each composed of 4 to 7 states.
Dementia diagnoses were based on International Classification of Diseases codes and calculated for zip codes within the CDC regions. Poisson regression models were used to calculate dementia incidence per 1000 person-years and assess regional differences in incidence rate ratios with several covariate models.
Among the 1 268 599 participants (mean age, 73.9 [SD, 6.1] years; n = 25 335 [2%] female), dementia incidence rates per 1000 person-years were lowest in the Mid-Atlantic (11.2; 95% CI, 11.1-11.4) and highest in the Southeast (14.0; 95% CI, 13.8-14.2). Compared with the Mid-Atlantic, the regions with the greatest demographically adjusted incidence included the Southeast (rate ratio [RR], 1.25; 95% CI, 1.22-1.28), Northwest (RR, 1.23; 95% CI, 1.20-1.27), Rocky Mountains (RR, 1.23; 95% CI, 1.20-1.26), South (RR, 1.18; 95% CI, 1.15-1.20), Midwest (RR, 1.12; 95% CI, 1.09-1.14), and South Atlantic (RR, 1.12; 95% CI, 1.10-1.14); the remaining regions had similar (<10% difference) incidence. Additional adjustments for rurality and cardiovascular comorbidities and accounting for the competing risk of death produced similar results.
Among older adults in the VHA, dementia incidence varied significantly across US regions, independent of key covariates. These findings highlight the need for targeted health care planning, public health interventions, and policy development.
美国此前关于痴呆症发病率的研究通常聚焦于狭窄区域,导致区域差异不明且潜在解释因素未知。
调查美国退伍军人健康管理局(VHA)系统中登记的老年人痴呆症发病率的地理差异。
设计、背景和人群:队列研究,时间跨度为1999年10月至2021年9月,平均随访时间为12.6年。对2023年10月至2024年9月期间年龄在65岁及以上、无痴呆症且在美国各地有可用邮政编码信息的1268599名退伍军人的随机样本数据进行分析。我们排除了22512名邮政编码缺失者、265850名无随访者以及37370名患有痴呆症者。
美国地理区域类别采用疾病控制和预防中心(CDC)慢性病预防与健康促进国家中心的定义,该定义将美国分为10个区域,每个区域由4至7个州组成。
痴呆症诊断基于国际疾病分类编码,并针对CDC区域内的邮政编码进行计算。采用泊松回归模型计算每1000人年的痴呆症发病率,并通过多个协变量模型评估发病率比值的区域差异。
在1268599名参与者中(平均年龄73.9[标准差6.1]岁;n = 25335[2%]为女性),每1000人年的痴呆症发病率在大西洋中部地区最低(11.2;95%置信区间,11.1 - 11.4),在东南部最高(14.0;95%置信区间,13.8 - 14.2)。与大西洋中部地区相比,人口统计学调整后发病率最高的区域包括东南部(发病率比值[RR],1.25;95%置信区间,1.22 - 1.28)、西北部(RR,1.23;95%置信区间,1.20 - 1.27)、落基山脉地区(RR,1.23;95%置信区间,1.20 - 1.26)、南部(RR,1.18;95%置信区间,1.15 - 1.20)、中西部(RR,1.12;95%置信区间,1.09 - 1.14)和南大西洋地区(RR,1.12;95%置信区间,1.10 - 1.14);其余区域发病率相似(差异<10%)。对农村地区和心血管合并症进行额外调整以及考虑死亡的竞争风险后,结果相似。
在VHA的老年人中,痴呆症发病率在美国各地区存在显著差异,与关键协变量无关。这些发现凸显了有针对性的医疗保健规划、公共卫生干预措施和政策制定的必要性。